Most GLP-1 telehealth services are slower, pricier, or murkier about their pharmacies than they need to be. Here is an honest look at six that actually hold up under scrutiny.
What Busy Professionals Actually Need From a GLP-1 Provider
You do not have time to chase a prior authorization for six weeks, wait three days for a physician response, or decode a fee structure designed to confuse you. The right platform ships fast, prices clearly, and keeps the medical oversight real without making you sit on hold.
What I Looked At
- Price transparency: cash-pay monthly cost, no surprise add-ons
- Speed: how quickly a physician reviews and medication ships
- Pharmacy credibility: named facility, third-party certification, quality standards
- Coverage: how many states the service reaches
- Medical oversight: is someone with actual training reviewing your case?
The 6 Best GLP-1 Platforms for Busy Professionals
1. HealthRX
The strongest all-around pick for professionals who want fast access, low cash pricing, and a named, verifiable pharmacy behind every vial.
HealthRX keeps the process tight. You fill out an online health assessment, a board-certified U.S. physician reviews it within about 24 hours, and medication ships overnight at no extra charge. Compounded semaglutide starts at $99 per month. Compounded tirzepatide starts at $149. Those are genuinely low numbers in a category where $299 to $399 per month is common. The pharmacy is not an unnamed facility somewhere vague. Manifest Pharmacy in Greer, South Carolina is a 503A compounding pharmacy operating under USP-797 standards with lot tracking from production through delivery, and the service carries LegitScript certification (certificate 50087439). Overnight delivery at no charge reaches every state in the country. That combination, low price plus named accredited pharmacy plus overnight reach, is harder to find together than you might expect. Clinical trials the platform references show tirzepatide producing roughly 21% body weight reduction at 72 weeks (SURMOUNT-1) and semaglutide roughly 15% at 68 weeks (STEP 1). These are compounded medications, not FDA-approved branded drugs, which is worth understanding before you start.
2. FormBlends
The pick if published lab data matters to you, or if you want GLP-1 treatment alongside a broader peptide protocol.
FormBlends runs a similar compounded GLP-1 model with physician oversight and an FDA-registered 503A pharmacy, but it does something few competitors bother with: it publishes per-product purity testing results, including HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility data. For professionals who come from science or compliance backgrounds and want to actually read the test results, that is meaningful. Compounded semaglutide is around $299 per vial and tirzepatide around $349, so the price is higher than HealthRX’s entry point. The service is available in 47 states, leaving out three. The platform also carries a wide peptide catalog covering recovery, longevity, and cognitive support under the same clinician model, which is unusual and useful if you want more than weight management from one provider. It ranks second here purely because HealthRX beats it on price and geographic reach for the GLP-1 use case specifically.
3. Mochi Health
Mochi uses board-certified obesity-medicine clinicians, not general practitioners, which makes a real difference in how medication decisions get made. Compounded semaglutide runs about $99 per month and compounded tirzepatide about $199. The monitoring is more involved than bare-bones platforms, which some people want and others find excessive. Good fit for someone who wants clinical depth alongside the convenience.
4. Hims & Hers
After the March 2026 Novo settlement, Hims & Hers moved away from compounded GLP-1s and shifted to branded medications. Injectable Wegovy is priced at roughly $299 monthly on the platform, oral options come in at about $249, and Zepbound sits closer to $399. With insurance and a manufacturer savings card, costs can drop to near zero. The brand is large, the app is polished, and customer support is responsive. Best for someone whose insurance plays nicely with branded GLP-1s.
5. Ro Body
Ro charges roughly $39 for the first month and $74 to $149 monthly after that, with medication billed separately. The prior-authorization team is a real differentiator: they actively work insurance on your behalf for branded meds, which can save significant money over time. The process is methodical rather than instant, so if you need medication in 48 hours, look elsewhere. Better for someone with good insurance and patience for the process.
6. PlushCare
PlushCare costs about $19.99 per month for membership and offers same-day telehealth visits, which is rare in this space. It works with insurance for branded GLP-1s. The platform is not GLP-1-specific, it covers general primary care too, so the weight-loss focus is thinner than dedicated services. Worth considering if you already want a primary care telehealth relationship and weight management is one piece of it.
How to Choose
Price and pharmacy transparency matter most for cash-pay patients. HealthRX wins on both for most people. If you want independent lab documentation of what is in your medication, FormBlends earns its higher price. If you have solid insurance coverage, Hims & Hers or Ro are worth running through your benefits. And if same-day access is your priority above everything else, PlushCare is built for that.
One note worth reading: the FDA issued warning letters to more than 30 telehealth and compounding firms in early 2026. Before starting any compounded GLP-1 program, verify the pharmacy credentials yourself rather than taking a platform’s word for it.
Common Questions
How fast can HealthRX actually get medication to me if I start today?
HealthRX physician review typically happens within 24 hours of submitting your health assessment. If approved, medication ships overnight at no added cost. For most professionals in the continental U.S., that means medication in hand within two to three days of starting the process, which is faster than most compounded GLP-1 services.
Is compounded semaglutide from any of these platforms the same drug as Ozempic or Wegovy?
No. Compounded semaglutide contains the same active molecule but is not manufactured by Novo Nordisk and is not FDA-approved as a finished drug product. Quality depends entirely on the compounding pharmacy. That is why pharmacy credentials, USP-797 compliance, and third-party purity testing from services like FormBlends matter more than the platform’s own marketing claims.
After the March 2026 Novo settlement, can Hims & Hers still prescribe semaglutide?
Hims & Hers shifted to branded medications following that settlement. They now offer Wegovy and Zepbound rather than compounded versions. Pricing runs $299 to $399 monthly before insurance or savings cards. If your employer health plan covers GLP-1s for obesity, that changes the math considerably in Hims & Hers’ favor.
Which of these platforms makes the most sense if I travel constantly for work and need reliable access across states?
HealthRX covers all 50 states with overnight shipping, making it the most travel-proof option for cash-pay patients on compounded medications. FormBlends reaches 47 states. PlushCare’s same-day telehealth visits work well for consultations while traveling, though medication logistics still depend on your shipping address.
Does Mochi Health’s obesity-medicine specialization actually change what medications get prescribed, or is it mostly a marketing angle?
It can make a real difference. Obesity-medicine board certification means clinicians are trained specifically in metabolic treatment, dosing adjustments, and managing side effects like GI distress during titration. General practitioners prescribing GLP-1s may have less experience with those specifics. Whether that depth justifies the trade-off in cost or speed depends on your medical history and how much clinical hand-holding you want.
Sources
- FDA: compounding pharmacy oversight and 503A regulations, FDA.gov
- SURMOUNT-1 trial (tirzepatide, 72 weeks): published in *The New England Journal of Medicine*, 2022
- STEP 1 trial (semaglutide, 68 weeks): published in *The New England Journal of Medicine*, 2021
- LegitScript pharmacy certification database, LegitScript.com
- Novo Nordisk settlement reporting, March 2026: *Reuters*, *Fierce Pharma*
- Hims & Hers investor disclosures and public pricing pages, 2026
